| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.097 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |